Global Thermoplastic Masks Market Size By Type (S-Type, U-Frame Type), By Application (Head Radiation Therapy, Neck Radiation Therapy), By Region, And Segment Forecasts, 2023 to 2032

lobal Thermoplastic Masks Market Report Description

The Global Thermoplastic Masks Market was valued at USD 415 million in 2023 and is projected to reach USD 712 million by 2031, growing at a CAGR of 6.9% during the forecast period from 2023 to 2031. Thermoplastic masks play a vital role in radiation therapy, offering patient immobilization for precise treatment delivery. The market growth is primarily driven by the rising prevalence of cancer worldwide, the growing adoption of radiotherapy, and advancements in thermoplastic mask materials that improve patient comfort and treatment accuracy. The increasing number of radiotherapy centers and growing awareness of the importance of immobilization during treatment are further boosting demand.

Drivers:

Rising Cancer Incidence Globally:

The increasing global burden of cancer, particularly head, neck, and brain cancers, has led to higher demand for radiotherapy, directly fueling the need for thermoplastic masks used in these treatments.

Advancements in Radiotherapy Techniques:

Technological innovations such as image-guided and intensity-modulated radiotherapy (IGRT and IMRT) require high-precision immobilization tools, boosting demand for thermoplastic masks.

Focus on Patient Comfort and Accuracy:

Improved mask designs that offer better fit, faster setup times, and reduced patient anxiety are contributing to widespread adoption in clinical settings.

Restraints:

High Cost of Advanced Masks and Equipment:

While thermoplastic masks are essential, the cost associated with advanced mask systems and their limited reuse increases treatment costs, particularly in low- and middle-income countries.

Limited Access in Developing Regions:

The lack of radiotherapy infrastructure in emerging markets restricts the adoption of thermoplastic masks despite growing cancer incidences.

Opportunity:

Expansion of Radiotherapy Centers in Emerging Markets:

Countries across Asia-Pacific, Latin America, and the Middle East are increasingly investing in radiotherapy infrastructure, offering significant growth opportunities for mask manufacturers.

Innovation in Customizable Mask Materials:

Ongoing R&D to create more flexible, environmentally friendly, and customizable mask materials opens doors for competitive product offerings and market expansion.

Market by System Type Insights:

Based on system type, the head and neck thermoplastic masks segment accounted for the largest market share in 2023. These masks are widely used in treatments for head and brain cancers due to their precision and effectiveness. Additionally, whole-body immobilization masks are gaining traction for their role in full-body treatments, such as in stereotactic body radiotherapy (SBRT), and are expected to witness significant growth.

Market by End-use Insights:

The hospitals segment emerged as the leading end-user in 2023, driven by the widespread availability of radiotherapy equipment and oncology departments. The radiotherapy centers segment is expected to grow at the fastest rate due to the global expansion of specialized cancer treatment facilities and increasing demand for outpatient cancer therapy services.

Market by Regional Insights:

In 2023, North America held the largest share of the global thermoplastic masks market, supported by high healthcare expenditure, advanced cancer treatment technologies, and a growing elderly population. However, Asia-Pacific is projected to register the highest CAGR during the forecast period, owing to increasing healthcare investments, a growing patient base, and government initiatives to improve oncology care access.

Competitive Scenario:

Key players operating in the global thermoplastic masks market include CIVCO Radiotherapy, Orfit Industries, Qfix, Klarity Medical, Elekta AB, IZI Medical Products, MacroMedics, and Med-Tec Systems. These companies focus on innovations in mask design and materials, strategic partnerships with oncology centers, and geographic expansion to maintain a competitive edge.

Recent Developments:

2023: Orfit Industries introduced a new generation of open-face thermoplastic masks, enhancing patient comfort while maintaining positioning accuracy.

2024: Qfix collaborated with leading radiotherapy equipment manufacturers to integrate smart mask technologies for real-time motion monitoring.

2025: Klarity Medical expanded its production facility in Asia to meet growing regional demand and reduce delivery lead times.

Scope of Work – Global Thermoplastic Masks Market

Report Metric Details

Market Size (2023) USD 415 million

Projected Market Size (2031) USD 712 million

CAGR (2023–2031) 6.9%

Market Segments